1. Acknowledgement to Referees

   Acknowledgement to Referees 19 November 2019 Pages: 595 - 598

2. Delivering on the Promise of Biosimilars

   • Arnold G. Vulto

   Commentary 12 October 2019 Pages: 599 - 602

3. An Efficient Development Paradigm for Biosimilars

   • Christopher J. Webster
   • Anny C. Wong
   • Gillian R. Woollett

   Current Opinion Open access 06 August 2019 Pages: 603 - 611

   

4. Different Cardiotoxicity of Palbociclib and Ribociclib in Breast Cancer: Gene Expression and Pharmacological Data Analyses, Biological Basis, and Therapeutic Implications

   • Matteo Santoni
   • Giulia Occhipinti
   • Nicola Battelli

   Current Opinion 16 September 2019 Pages: 613 - 620

   

5. Evolution of the EU Biosimilar Framework: Past and Future

   • Elena Wolff-Holz
   • Klara Tiitso
   • Martina Weise

   Review Article Open access 20 September 2019 Pages: 621 - 634

6. Extrapolation in Practice: Lessons from 10 Years with Biosimilar Filgrastim

   • Pere Gascon
   • Andriy Krendyukov
   • Matti Aapro

   Review Article Open access 22 August 2019 Pages: 635 - 645

7. CAR-T Engineering: Optimizing Signal Transduction and Effector Mechanisms

   • Emiliano Roselli
   • Jeremy S. Frieling
   • Daniel Abate-Daga

   Review Article 24 September 2019 Pages: 647 - 659

   

8. Assessment of the Molecular Mechanism of Action of SB3, a Trastuzumab Biosimilar

   • Kyungyeol Paek
   • Go-woon Kim
   • Jae Hee Lee

   Original Research Article Open access 23 September 2019 Pages: 661 - 671

   

9. Steady-State Plasma Concentrations of Polyethylene Glycol (PEG) are Reached in Children and Adults During Once-Weekly Prophylactic Treatment with Nonacog Beta Pegol (N9-GP)

   • Ola Sternebring
   • Charlotte Gabel-Jensen
   • Inga Bjørnsdottir

   Original Research Article Open access 23 September 2019 Pages: 673 - 681

   

10. Analysis of Immunogenicity Data in the Product Information of Biological Drugs: A Need to Report Immunogenicity Data Systematically

    • Rodrigo Borrega
    • Joao Paulo Cruz
    • Joao Goncalves

    Original Research Article 08 October 2019 Pages: 683 - 691

    

11. Biosimilars: An Opportunity to Update the Product Information of Biological Drugs Regarding their Immunogenicity

    • Rodrigo Borrega
    • Joao Paulo Cruz
    • Joao Goncalves

    Letter to the Editor 25 October 2019 Pages: 693 - 695